SOURCE: TomoTherapy

TomoTherapy

November 23, 2010 14:10 ET

TomoTherapy and NELCO Partner to Reduce Radiation Therapy Construction Costs

Total Shield™ for TomoTherapy® Cuts Costs, Time Associated With Renovation of Treatment Vaults

MADISON, WI--(Marketwire - November 23, 2010) - TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced availability of a shielding solution that enables hospitals and cancer centers to quickly, easily and inexpensively build out treatment vaults that are properly shielded for use of the TomoTherapy® radiation therapy system. The Total Shield by NELCO, the worldwide leader in designing, manufacturing, and installing specialized products and services for the medical, industrial, and construction fields, is a customized shielding enclosure designed to fit around a TomoTherapy unit, making it possible for the radiation therapy system to be placed into existing under-shielded vaults or other treatment rooms where there may not be enough space to install necessary shielding using the existing infrastructure.

Total Shield provides hospitals and cancer centers with the flexibility to put the TomoTherapy system in an existing space, which may be too small or may not include enough shielding for modern intensity-modulated radiation therapy (IMRT) devices. Instead of adding shielding in the walls, the Total Shield enclosure is designed to wrap around the TomoTherapy system itself.

By taking this approach, TomoTherapy customers can potentially save hundreds of thousands of dollars in shielding costs and eliminate the months it takes to install conventional shielding solutions. Total Shield can be installed in just a matter of days. Additionally, because the Total Shield can be easily removed, it can be reused if the TomoTherapy system is eventually moved to a new location.

"Total Shield is the most recent example of how the TomoTherapy system's unique design, and its small footprint, can allow hospitals and cancer centers to easily adopt cutting-edge cancer care technology in places where other solutions are not feasible," said Harry Freeman, director of commercial operations at TomoTherapy. "Combined with the TomoTherapy system's integrated beam stop technology, Total Shield can dramatically reduce the cost of building out a vault with extensive shielding, and enables facilities to get their TomoTherapy system up and running much quicker than other radiation treatment solutions."

Total Shield was designed collaboratively by NELCO and will be on display in the TomoTherapy booth (#6406) at RSNA 2010, November 28 – December 3, at McCormick Place in Chicago, Illinois.

About NELCO 
NELCO, an ISO 9001:2008 certified company, is an industry leader in the design, manufacturing, and installation of specialized products and services, for the medical, industrial, and construction fields. Such products include shielding for medical radiation therapy, medical diagnostic imaging, anti-corrosive linings, and industrial radiation shielding. With offices around the US, United Arab Emirates, the United Kingdom and China, NELCO always has a facility nearby, cutting shipping costs, and helping excel in customer service. For more information, visit http://www.nelcoworldwide.com, or call 1-781-933-1940.

About TomoTherapy Incorporated 
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy's suite of solutions includes its flagship Hi·Art® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

©2010 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, TomoHD, TomoDirect, TQA, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

Contact Information

  • Investor Contact:
    Thomas E. Powell
    Chief Financial Officer
    608.824.2800
    Email Contact

    Media Contacts:
    Kevin O'Malley
    Manager, Corporate Communications
    608.824.3384
    Email Contact

    Susan Lehman
    Rockpoint Public Relations
    510.832.6006
    Email Contact